Default company panoramic image
Logo

MediBeacon, LLC

To commercialize optical diagnostic agents for monitoring and intraoperative surgery, with a novel renal function device as first product.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded February 2012
  • Employees 3
  • Website MediBeacon.com

Company Summary

MediBeacon, LLC. is an optical diagnostics company to commercialize biocompatible optical diagnostic agents for monitoring, surgical guidance, and imaging. MediBeacon’s ORFM System will be the first real-time, accurate, cost-effective, non-radioactive and easy to use monitor of kidney function. This real-time monitor of kidney function will allow for earlier detection of renal issues enabling clinicians to provide earlier effective interventions.

Team

  • Default avatar
    Steven J Hanley
    CEO

    Mr. Hanley is the former president of Covidien’s Imaging Solutions business unit with annual global revenue exceeding $1 billion. He led a multifunctional organization that included sales, marketing, logistics, manufacturing, as well as research and development. He has over 20 years experience selling and marketing medical device and pharmaceutical technologies globally.

  • Default avatar
    Richard B Dorshow
    Chief Scientific Officer

    Dr. Dorshow is a research physicist and manager with over 25 years in R&D focusing on business oriented research programs. He established and led the optical diagnostics and therapeutics program at Mallinckrodt. He constructed its IP position, and is co-inventor on over 60 US patents. He had the unique opportunity to launch MediBeacon under which he led acquisition of the technology, market research, IP and other related assets from Covidien.

  • Default avatar
    Terence H Stern
    Vice President Business Development

    Mr. Stern is a multi-lingual, global executive with a record of entrepreneurial achievement in the life sciences. As CEO and Founder of Vetbrands International he led the private equity backed management buyout of Ralston Purina’s pharmaceutical business in 2002 culminating in the sale of this Brazilian business to Ceva Santé Animale in 2007. Mr. Stern also held various general management and corporate development roles at Novus International.

Advisors

  • Default avatar
    Andrew Hoyne, Esq., Polsinelli Shughart
    Lawyer
    Unconfirmed
    Default avatar
    Stone Carlie
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    BioGenerator
    Unconfirmed
    Default avatar
    Missouri Technology Corporation
    Unconfirmed
    Default avatar
    Saint Louis Development Corporation
    Unconfirmed